UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043189
Receipt number R000049293
Scientific Title Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial
Date of disclosure of the study information 2021/01/30
Last modified on 2021/08/01 13:58:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Acronym

An educational program to reduce the stigma of schizophrenia among community pharmacists

Scientific Title

Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Scientific Title:Acronym

An educational program to reduce the stigma of schizophrenia among community pharmacists

Region

Japan


Condition

Condition

General population

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate that a combining the educational interventions based on lecture of schizophrenia and communication with patients improve the stigma toward people with schizophrenia among community pharmacists by using a newly developed Stigma Scale towards Schizophrenia for Community Pharmacists

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The amount of change in the degree of stigma for schizophrenia patients before and after intervention by using the Stigma Scale towards Schizophrenia for Community Pharmacists

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

A 60-minute communicating with patients with schizophrenia and a 60-minute lecture on schizophrenia

Interventions/Control_2

A 60-minute lecture on schizophrenia

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

A community pharmacist with over a year of work experience as a pharmacist

Key exclusion criteria

A community pharmacist with less than a year of work experience as a pharmacist
A pharmacist who works outside the insurance pharmacy

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Kamei

Organization

Meijo University

Division name

Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy

Zip code

468-8503

Address

150 Yagotoyama, Tempaku-ku, Nagoya, Aichi

TEL

052-839-2643

Email

hkamei@meijo-u.ac.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Kamei

Organization

Meijo University

Division name

Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy

Zip code

468-8503

Address

150 Yagotoyama, Tempaku-ku, Nagoya, Aichi

TEL

052-839-2643

Homepage URL


Email

hkamei@meijo-u.ac.jp


Sponsor or person

Institute

Meijo University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Meijo University Research Ethics Board

Address

1-501 Shiogamaguchi, Tempaku-ku, Nagoya, Aichi

Tel

0528382034

Email

souken@ccml.meijo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 30 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000049293

Publication of results

Unpublished


Result

URL related to results and publications

https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Number of participants that the trial has enrolled

115

Results

Educational program-related changes of the median (interquartile range) total SSCP score from baseline were -9.0(-16.0- -5.0) in the contact-based intervention group and -3.0(-7.0- 1.0) in the educational lecture group, reflecting a significant reduction of stigma levels in the contact-based intervention group.

Results date posted

2021 Year 08 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

115 community pharmacists

Participant flow

Participants were individually allocated to two groups: educational lecture group (56; only attending a lecture on schizophrenia) or contact-based intervention group (59; communicating with patients diagnosed with schizophrenia and attending the lecture).

Adverse events

N/A

Outcome measures

Stigma Scale towards Schizophrenia for Community Pharmacists (SSCP)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 06 Month 01 Day

Date of IRB

2018 Year 08 Month 22 Day

Anticipated trial start date

2019 Year 05 Month 13 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 30 Day

Last modified on

2021 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049293


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name